Kaiseraugst, Switzerland

Patricia Imbach-Weese

USPTO Granted Patents = 4 

Average Co-Inventor Count = 6.5

ph-index = 2

Forward Citations = 7(Granted Patents)


Location History:

  • Kaiseraugst, CH (2013 - 2014)
  • Bielefeld, DE (2023)

Company Filing History:


Years Active: 2013-2023

Loading Chart...
4 patents (USPTO):Explore Patents

Title: **Patricia Imbach-Weese: Innovator in Pharmaceutical Chemistry**

Introduction

Patricia Imbach-Weese is an accomplished inventor based in Kaiseraugst, Switzerland. With a specialization in pharmaceutical chemistry, she has significantly contributed to the field through her innovative inventions. With a total of four patents to her name, she exemplifies the dedication and creativity required to advance medical research and improve treatment options.

Latest Patents

Patricia's latest inventions include groundbreaking compounds aimed at inhibiting Bruton's Tyrosine Kinase. One notable patent describes substituted pyrrolo[2,3-d]pyrimidines, which are designed for use in the treatment of various diseases. The invention encompasses compounds represented by a specific formula and includes a detailed discussion of their pharmaceutically acceptable salts. Another recent patent focuses on 3-hydroxy-N-(3-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)pyrrolidine-1-carboxamide derivatives, illustrating her commitment to discovering new therapeutic options.

Career Highlights

Patricia is currently employed at Novartis AG, a global healthcare company recognized for its innovative approach to pharmaceuticals. Here, she has played a vital role in research and development, translating complex scientific concepts into viable medical treatments. Her work not only contributes to the company's success but also to the overall advancement of healthcare.

Collaborations

Throughout her career, Patricia has collaborated with esteemed colleagues such as Robin Alec Fairhurst and Vito Guagnano. These partnerships highlight her ability to work within teams, fostering a collaborative environment that is essential for advancing scientific discoveries.

Conclusion

Patricia Imbach-Weese continues to be a driving force in the field of pharmaceutical chemistry. With her impressive portfolio of patents and her influential collaborations, she remains at the forefront of innovation in healthcare. Her work not only reflects her dedication as an inventor but also her commitment to improving patient outcomes through scientific advancement.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…